Shawn Griffin, PharmD, reviews strategies to tackle socioeconomic challenges in myelofibrosis treatment, covering costs, transportation, language barriers, cultural sensitivity, and patient communication.
Pharmacists discuss tailored patient education approaches, emphasizing key medication details, side effects, and financial aspects critical for myelofibrosis care, optimizing adherence and healthcare outcomes.
Aaron Gerds, MD, MS, compares myelofibrosis with other myeloproliferative neoplasms, explores its prevalence in the US, and reviews the diverse clinical presentations and the impact on patients’ quality of life.
Kristen Peterson, PharmD, BCOP, discusses how pharmacists optimize quality of life for patients with multiple myeloma, manage treatment side effects, and adapt amidst healthcare shortages while staying updated on the latest advancements for comprehensive patient care.
Experts discuss obstacles faced during transitioning myelofibrosis patients from inpatient to outpatient care, emphasizing communication, access to medication, and the need for standardized medication reconciliation protocols.